Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The company’s OneRF Ablation System is the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously, representing a significant advancement in epilepsy treatment [3][4] Company Overview - NeuroOne develops minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for conditions such as epilepsy, Parkinson's disease, and chronic pain [5] - The OneRF system includes an electrode for brain activity monitoring and ablation, a temperature probe, and a radio frequency heat generator [3] Market Context - Over 50 million people globally are affected by epilepsy, with about one-third experiencing medication-resistant seizures, highlighting the need for alternative treatments like RF ablation therapy [2] - The OneRF platform has potential applications beyond epilepsy, including pain management and other neurological disorders [4][5]
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update